Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lock Kenneth A.
Chief Commercial Officer at Arcutis Biotherapeutics. Filing since 1 Mar 2021.
CIK 0001801047
Company
Date
Role
Action
Shares
Amount
Of holding
ARQT
Arcutis Biotherapeutics, Inc.
6 Mar 2023
Chief Commercial Officer
Sold, plan not stated
831
$12.68K
1.3%
ARQT
Arcutis Biotherapeutics, Inc.
2 Mar 2023
Chief Commercial Officer
Sold, plan not stated
1,432
$22.66K
3.2%
ARQT
Arcutis Biotherapeutics, Inc.
28 Feb 2023
Chief Commercial Officer
Sold, plan not stated
936
$15.13K
2.1%
ARQT
Arcutis Biotherapeutics, Inc.
7 Mar 2022
Chief Commercial Officer
Sold, plan not stated
30
$493.35
0.1%
ARQT
Arcutis Biotherapeutics, Inc.
4 Mar 2022
Chief Commercial Officer
Sold, plan not stated
993
$16.74K
2.2%
ARQT
Arcutis Biotherapeutics, Inc.
1 Mar 2022
Chief Commercial Officer
Sold, plan not stated
935
$16.60K
2.9%
ARQT
Arcutis Biotherapeutics, Inc.
1 Mar 2021
Chief Commercial Officer
Sold, plan not stated
933
$31.91K
4.0%
7 decisions on file.
